Home NDC 71335-1092 Alprazolam
Product NDC 71335-1092
11-digit product format 713351092
Labeler code 71335
Product ID 71335-1092_a5428249-48c5-4489-bf0b-80ab586277da
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Alprazolam
Dosage form TABLET
Route ORAL
Labeler Bryant Ranch Prepack
Application ANDA207507
Marketing category ANDA
Marketing start 2018-07-09
Marketing end 0000-00-00
Substance ALPRAZOLAM
Active strength 1 mg/1
Pharmacologic classes Benzodiazepine [EPC], Benzodiazepines [CS]
DEA schedule CIV
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 33 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-6 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-3 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-4 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-2 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-8 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-9 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-5 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-7 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-0 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 71335-1092-1 D Discontinued by firm d630ba8d3edf…732f749b63fb…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-8 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-2 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-3 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-7 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-5 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-9 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-1 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-0 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-6 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 71335-1092-4 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-8 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-2 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-3 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-7 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-5 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-9 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-1 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-0 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-6 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 71335-1092-4 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A207507-001 ALPRAZOLAM ALPRAZOLAM 0.25MG TABLET / ORAL 2018-07-09 A207507-002 ALPRAZOLAM ALPRAZOLAM 0.5MG TABLET / ORAL 2018-07-09 A207507-003 ALPRAZOLAM ALPRAZOLAM 1MG TABLET / ORAL 2018-07-09 A207507-004 ALPRAZOLAM ALPRAZOLAM 2MG TABLET / ORAL 2018-07-09
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL 2018-07-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL 2018-07-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL 2018-07-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL 2018-07-09 84e616aacf4f…2026-08-18 06:07:40 2026-07 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL 2018-07-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL 2018-07-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL 2018-07-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL 2018-07-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL 2018-07-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL 2018-07-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL 2018-07-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL 2018-07-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL 2018-07-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL 2018-07-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL 2018-07-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL 2018-07-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 2018-07-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 2018-07-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL AB 2018-07-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL AB 2018-07-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 2018-07-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 2018-07-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL AB 2018-07-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL AB 2018-07-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 2018-07-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 2018-07-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL AB 2018-07-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL AB 2018-07-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 2018-07-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 2018-07-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL AB 2018-07-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL AB 2018-07-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 2018-07-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 2018-07-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL AB 2018-07-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL AB 2018-07-09 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207507-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 2018-07-09 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207507-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 2018-07-09 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207507-003 ALPRAZOLAM 1MG TABLET / ORAL AB 2018-07-09 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207507-004 ALPRAZOLAM 2MG TABLET / ORAL AB 2018-07-09 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 152 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 71335-1092-0 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-1 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-2 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-3 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-4 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-5 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-6 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-7 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-8 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-9 2024-05-17 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-0 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-1 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-2 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-3 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-4 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-5 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-6 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-7 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-8 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981 71335-1092-9 2024-01-30 These highlights do not include all the information needed to use ALPRAZOLAM TABLETS safely and effectively. See full prescribing information for ALPRAZOLAM TABLETS. ALPRAZOLAM tablets, for oral use, CIV Initial U.S. Approval: 1981
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71335-1092 ALPRAZOLAM TABLET [BRYANT RANCH PREPACK] 7 Legacy NDC 20240518_a5428249-48c5-4489-bf0b-80ab586277da.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 71335-1092-0 71335109200 10 TABLET in 1 BOTTLE (71335-1092-0) 10 tablet 2019-02-08 0000-00-00 No No Current 71335-1092-1 71335109201 15 TABLET in 1 BOTTLE (71335-1092-1) 15 tablet 2019-02-08 0000-00-00 No No Current 71335-1092-2 71335109202 30 TABLET in 1 BOTTLE (71335-1092-2) 30 tablet 2019-02-08 0000-00-00 No No Current 71335-1092-3 71335109203 20 TABLET in 1 BOTTLE (71335-1092-3) 20 tablet 2019-02-08 0000-00-00 No No Current 71335-1092-4 71335109204 100 TABLET in 1 BOTTLE (71335-1092-4) 100 tablet 2019-02-08 0000-00-00 No No Current 71335-1092-5 71335109205 90 TABLET in 1 BOTTLE (71335-1092-5) 90 tablet 2019-02-08 0000-00-00 No No Current 71335-1092-6 71335109206 60 TABLET in 1 BOTTLE (71335-1092-6) 60 tablet 2019-02-08 0000-00-00 No No Current 71335-1092-7 71335109207 120 TABLET in 1 BOTTLE (71335-1092-7) 120 tablet 2019-02-08 0000-00-00 No No Current 71335-1092-8 71335109208 28 TABLET in 1 BOTTLE (71335-1092-8) 28 tablet 2019-02-08 0000-00-00 No No Current 71335-1092-9 71335109209 2 TABLET in 1 BOTTLE (71335-1092-9) 2 tablet 2019-02-08 0000-00-00 No No Current